Literature DB >> 8382993

The binding domain structure of retinoblastoma-binding proteins.

J Figge1, K Breese, S Vajda, Q L Zhu, L Eisele, T T Andersen, R MacColl, T Friedrich, T F Smith.   

Abstract

The retinoblastoma gene product (Rb), a cellular growth suppressor, complexes with viral and cellular proteins that contain a specific binding domain incorporating three invariant residues: Leu-X-Cys-X-Glu, where X denotes a nonconserved residue. Hydrophobic and electrostatic properties are strongly conserved in this segment even though the nonconserved amino acids vary considerably from one Rb-binding protein to another. In this report, we present a diagnostic computer pattern for a high-affinity Rb-binding domain featuring the three conserved residues as well as the conserved physico-chemical properties. Although the pattern encompasses only 10 residues (with only 4 of these explicitly defined), it exhibits 100% sensitivity and 99.95% specificity in database searches. This implies that a certain pattern of structural and physico-chemical properties encoded by this short sequence is sufficient to govern specific Rb binding. We also present evidence that the secondary structural conformation through this region is important for effective Rb binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382993      PMCID: PMC2142352          DOI: 10.1002/pro.5560020204

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

2.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

3.  Helix-coil transition of the isolated amino terminus of ribonuclease.

Authors:  J E Brown; W A Klee
Journal:  Biochemistry       Date:  1971-02-02       Impact factor: 3.162

4.  Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP.

Authors:  S S Zimmerman; M S Pottle; G Némethy; H A Scheraga
Journal:  Macromolecules       Date:  1977 Jan-Feb       Impact factor: 5.985

5.  Molecular weight determinations of proteins by californium plasma desorption mass spectrometry.

Authors:  B Sundqvist; P Roepstorff; J Fohlman; A Hedin; P Håkansson; I Kamensky; M Lindberg; M Salehpour; G Säwe
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

Review 6.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 7.  Role of the human papillomaviruses in human cancer.

Authors:  P M Howley
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

8.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.

Authors:  A K Rustgi; N Dyson; R Bernards
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

9.  Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.

Authors:  D V Heck; C L Yee; P M Howley; K Münger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

10.  The release of growth arrest by microinjection of adenovirus E1A DNA.

Authors:  S Stabel; P Argos; L Philipson
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

View more
  3 in total

1.  Protein-peptide interactions analyzed with the yeast two-hybrid system.

Authors:  M Yang; Z Wu; S Fields
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

2.  Characterization of CELO virus proteins that modulate the pRb/E2F pathway.

Authors:  H Lehrmann; M Cotten
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  A competitive inhibitor assay for SV40 T/pRB complex formation employing extracts of SV40-transformed human lung cells.

Authors:  K Breese; T Friedrich; J Figge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.